Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Creative Commons License

Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., ...Daha Fazla

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.31, sa.1, ss.49-56, 2022 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4274/mirt.galenos.2022.59140
  • Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.49-56
  • Anahtar Kelimeler: Breast cancer, PET/CT, fluorodeoxyglucose, hormone receptor, CANCER, ESTROGEN, FEATURES, VOLUME, SUV
  • Ankara Üniversitesi Adresli: Evet

Özet

Objectives: This study aimed to investigate the role of preoperative 'fluorine-fluorodeoxyglucose (F-18-FDG) positron emission tomography/ computed tomography (PET/CT) radiomics features and metabolic parameters of primary breast tumors in predicting hormone receptor (HR) positivity.